ES2053525T3 - Acidos hidroxamicos. - Google Patents
Acidos hidroxamicos.Info
- Publication number
- ES2053525T3 ES2053525T3 ES87300366T ES87300366T ES2053525T3 ES 2053525 T3 ES2053525 T3 ES 2053525T3 ES 87300366 T ES87300366 T ES 87300366T ES 87300366 T ES87300366 T ES 87300366T ES 2053525 T3 ES2053525 T3 ES 2053525T3
- Authority
- ES
- Spain
- Prior art keywords
- hydroxamic acids
- acids
- formula
- amino acid
- acid residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA INVENCION PROPORCIONA UNA SERIE DE ACIDOS NUEVOS DE FORMULA I QUE SON UTILES COMO INHIBIDORES DE METALOPROTEASAS TALES COMO ENDOPEPTIDASAS Y EN LA QUE R1 ES UN GRUPO HIDROFOBO, R2 Y R3 SON CADA UNO UN RESTO DE AMINOACIDO, N ES 1 O 2, Y A ES UN GRUPO DE FORMULA: -CHR4.CO.NH2 EN LA QUE R4 ES UN RESTO DE AMINOACIDO. TAMBIEN SE DESCRIBEN PROCESOS PARA LA FABRICACION DE LOS ACIDOS HIDROXAMICOS, SALES FARMACOLOGICAMENTE ACEPTABLES DE DICHOS ACIDOS Y COMPOSICIONES FARMACOLOGICAS QUE CONTIENEN UNO DE ESTOS ACIDOS O SALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868601368A GB8601368D0 (en) | 1986-01-21 | 1986-01-21 | Hydroxamic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053525T3 true ES2053525T3 (es) | 1994-08-01 |
Family
ID=10591684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87300366T Expired - Lifetime ES2053525T3 (es) | 1986-01-21 | 1987-01-16 | Acidos hidroxamicos. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0231081B1 (es) |
JP (1) | JP2532859B2 (es) |
AT (1) | ATE87005T1 (es) |
DE (1) | DE3784743T2 (es) |
ES (1) | ES2053525T3 (es) |
GB (1) | GB8601368D0 (es) |
GR (1) | GR3007389T3 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991008222A1 (fr) * | 1989-11-24 | 1991-06-13 | Banyu Pharmaceutical Co., Ltd. | Substance physiologiquement active be-16627 |
GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
AU666727B2 (en) * | 1992-06-25 | 1996-02-22 | F. Hoffmann-La Roche Ag | Hydroxamic acid derivatives |
GB9213473D0 (en) * | 1992-06-25 | 1992-08-12 | Hoffmann La Roche | Hydroxamic acid derivatives |
US5594106A (en) * | 1993-08-23 | 1997-01-14 | Immunex Corporation | Inhibitors of TNF-α secretion |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
CZ62899A3 (cs) * | 1996-08-28 | 1999-07-14 | The Procter & Gamble Company | 1,3-Diheterocyklické metaloproteázové inhibitory |
JP3539736B2 (ja) * | 1996-08-28 | 2004-07-07 | ザ プロクター アンド ギャンブル カンパニー | 基質メタロプロテアーゼインヒビターとしてのホスフィン酸アミド |
AU731319B2 (en) * | 1996-08-28 | 2001-03-29 | Procter & Gamble Company, The | Heterocyclic metalloprotease inhibitors |
HUP0000210A3 (en) | 1996-08-28 | 2001-07-30 | Procter And Gamble Co Cincinna | Heterocyclic compounds as metalloprotease inhibitors and use of them for producing pharmaceutical compisitions |
ATE272062T1 (de) * | 1996-08-28 | 2004-08-15 | Procter & Gamble | Spirocyclisch metalloprotease inhibitoren |
EP0925278B1 (en) | 1996-09-10 | 2002-07-17 | British Biotech Pharmaceuticals Limited | Cytostatic hydroxamic acid derivatives |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
EP1009737A2 (en) | 1997-07-31 | 2000-06-21 | The Procter & Gamble Company | Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
WO2000051975A1 (en) | 1999-03-03 | 2000-09-08 | The Procter & Gamble Company | Alkenyl- and alkynyl-containing metalloprotease inhibitors |
AU2001271068A1 (en) * | 2000-07-18 | 2002-01-30 | Chugai Seiyaku Kabushiki Kaisha | Matrix metalloprotease inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518088B1 (fr) * | 1981-12-16 | 1987-11-27 | Roques Bernard | Nouveaux derives d'aminoacides, et leur application therapeutique |
US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
-
1986
- 1986-01-21 GB GB868601368A patent/GB8601368D0/en active Pending
-
1987
- 1987-01-16 DE DE8787300366T patent/DE3784743T2/de not_active Expired - Lifetime
- 1987-01-16 AT AT87300366T patent/ATE87005T1/de not_active IP Right Cessation
- 1987-01-16 ES ES87300366T patent/ES2053525T3/es not_active Expired - Lifetime
- 1987-01-16 EP EP87300366A patent/EP0231081B1/en not_active Expired - Lifetime
- 1987-01-20 JP JP62009207A patent/JP2532859B2/ja not_active Expired - Lifetime
-
1993
- 1993-03-18 GR GR920402603T patent/GR3007389T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0231081A2 (en) | 1987-08-05 |
JPS62228097A (ja) | 1987-10-06 |
DE3784743D1 (en) | 1993-04-22 |
ATE87005T1 (de) | 1993-04-15 |
GR3007389T3 (es) | 1993-07-30 |
GB8601368D0 (en) | 1986-02-26 |
EP0231081A3 (en) | 1989-11-15 |
DE3784743T2 (de) | 1993-06-24 |
EP0231081B1 (en) | 1993-03-17 |
JP2532859B2 (ja) | 1996-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053525T3 (es) | Acidos hidroxamicos. | |
DZ1405A1 (fr) | Dérivés de n-(3-hydroxy-4-piperidinyl)(dihydro-benzofuranne, dihydro-2h-benzopy-ranne ou dishydro-benzodioxin)carboxamide. | |
FI850078A0 (fi) | N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat. | |
BR9305162A (pt) | Composto, formulação farmacêutica e processo para a preparação de um composto | |
LV5738A4 (lv) | Aminoskabju atvasinajumi | |
DK0412404T3 (da) | Thiazolderivater, fremgangsmåder til fremstilling deraf og farmaceutiske præparater omfattende derivaterne | |
PT88577A (pt) | Process for the manufacture of novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides | |
ES8305695A1 (es) | Procedimiento para preparar derivados de amidas. | |
BR9305164A (pt) | Composto, formulação farmacêutica e processo para preparar um composto | |
AU590172B2 (en) | Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof | |
ATE48001T1 (de) | Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate. | |
NO894349D0 (no) | Tienopyridin-type mevalonolaktoner. | |
FR2558837B1 (fr) | Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant | |
AU3895689A (en) | Cyclic sulfur-containing amino acid derivatives | |
PH21632A (en) | Process for preparing n-substituted amido amino acid | |
ES2054989T3 (es) | Derivados de aminodiol inhibidores de renina. | |
ES2061945T3 (es) | Procedimiento para preparar fosfonil-hidroxiacil-prolinas. | |
ATE46347T1 (de) | Immunostimulierende peptide. | |
ZA9610804B (en) | 4-Imidazolidinone compound process for its preparation and the pharmaceutical compositions which contain it | |
DE3587915D1 (de) | Verfahren zur Herstellung von Cephalosporinen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 231081 Country of ref document: ES |